Koral Shah, MD, details the rationale of evaluating worldwide disparities in bladder cancer clinical trial availability.
Koral Shah, MD
Advertisement
Koral Shah, MD, is a fellow in Hematology & Medical Oncology at City of Hope in Duarte, California.
Articles by Koral Shah, MD
Advertisement
Latest Updated Articles
Dr Shah on Disparities in Worldwide Bladder Cancer Trial AvailabilityPublished: March 5th 2025 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
FDA Accepts BLA for Ivonescimab Plus Chemotherapy in EGFR-Mutant NSCLC After TKI Progression
2
FDA Approval Sought for Lirafugratinib in Second-Line, FGFR2-Altered Cholangiocarcinoma
3
2025 Data Across Gynecologic, Lung, and Hematologic Cancers Reshape Treatment Landscapes
4
Dr Spencer on First-Line Chemo Selection in Metastatic Pancreatic Adenocarcinoma
5